BioCanada

Found 23,108 articles

• BMO Insurance to Offer Advance Payment of Life Insurance Benefit in Case of Financial Hardship

  10/15/2019

  BMO Insurance Financial Hardship Life Advance offered to those in financial difficulty and who have a life expectancy of five years or less

• Titan Medical Announces Filing of Amended and Restated Preliminary Prospectus and Withdrawal of Previously Published Milestones

  10/15/2019

  The A&R Preliminary Prospectus and Registration Statement are subject to completion and amendment.

• Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019

  10/15/2019

  Valens GroWorks Corp. (TSXV: VGW) (OTC: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab is pleased to report its financial results for the third quarter of fiscal 2019.

• Synaptive Medical Presents Key Features of Its Modus V™ Robotic Surgical Microscopy Technology at the 2019 CNS Annual Meeting

  10/15/2019

  Synaptive Medical, a leader in automation and robotics, will deliver two presentations showcasing the capabilities of Modus V, Synaptive’s robotically controlled digital microscope designed for use in cranial and spinal procedures, during the 2019 Congress of Neurological Surgeons (CNS) Annual Meeting.

• Avricore Health Appoints CEO, President and Advisors

  10/15/2019

  Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) Board of Directors announces the appointment of Hector Bremner as Chief Executive Officer and Bob Rai as President effective immediately.

• Sienna Announces October Dividend

  10/15/2019

  Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of October 2019, representing $0.936 per Common Share on an annualized basis.

• Harborside Inc. Announces Extension of Voluntary Lock-Up Agreements with Key Executives, Board Members and Insiders

  10/15/2019

  Harborside Inc. ("Harborside" or the "Company") (CSE: HBOR), a California-focused, vertically integrated cannabis enterprise, announced today that key executives, members of the Board of Directors and insiders, have entered into an additional, extended voluntary lock-up agreement with the Company,

• Abacus Health Products Enters U.S. Convenience Store Market With New Distribution Agreement

  10/15/2019

  Abacus Health Products, Inc. (CSE: ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) today announced that it would be entering the convenience store market segment through an agreement with E&S International Enterprises, Inc. (“ESI”), for the distribution of CBDMEDIC™ products to this channel.

• Avivagen Announces Proposed Extension of Warrants

  10/15/2019

  Avivagen Inc. announced that it will be requesting approval from the TSX Venture Exchange for the extension of the expiration date of warrants exercisable to purchase 1,163,738 common shares at $1.00 per share which were originally issued on December 16, 2014 and warrants exercisable to purchase 2,774,991 common shares at $0.90 per share which were originally issued on June 1, 2016.

• Nextleaf Solutions Enters into Agreement to Consolidate Nextleaf Labs

  10/15/2019

  Nextleaf Solutions Ltd. ("Nextleaf", "OILS", or the "Company") (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) a Vancouver-based extraction technology company that owns a portfolio of eight (8) issued and over 35 pending patents pertaining to industrial-scale extraction, purification and formulation of cannabinoids, announced today that it has entered into an agreement with its commercialization partner, Nextleaf Labs Ltd. ("Labs"

• Extendicare Announces October 2019 Dividend of C$0.04 per Share

  10/15/2019

  Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of October 2019, which is payable on November 15, 2019 to shareholders of record at the close of business on October 31, 2019

• Emerald Health Therapeutics Announces Update On Pure Sunfarms Supply Agreement

  10/15/2019

  Emerald Health Therapeutics announced that it has notified Pure Sunfarms Corp., its 50%-owned joint venture, that it does not agree that Emerald has any liability under the current Supply Agreement between Emerald and the Joint Venture with respect to the Joint Venture’s recent sales of cannabis to third parties at prices below the predetermined purchase price to Emerald set out in the Supply Agreement.

• Emerald Health Therapeutics’ Metro Vancouver Organic Cannabis Operation Receives Cultivation Expansion License for Total Growing Area in First GreenhouseEmerald organic site will now scale into commercial greenhouse production

  10/15/2019

  Emerald Health Therapeutics has received from Health Canada its cultivation license amendment and has full municipal permitting for its first of two 78,000 square foot greenhouses at its organic Metro Vancouver site in British Columbia.

• Neovasc Announces Notice of US Patent Granted for Tiara™ Transcatheter Device for Treatment of Severe Mitral Regurgitation

  10/15/2019

  Neovasc, Inc. announced that the United States Patent and Trademark Office has issued US Patent No. 10,433,952, titled: “PROSTHETIC VALVE FOR AVOIDING OBSTRUCTION OF OUTFLOW”.

• Forbius Completes Enrollment into Phase 1a Solid Tumor Trial of AVID200, First-in-Class TGF-beta 1 & 3 Inhibitor; Closes Series C Financing

  10/14/2019

  AVID200 is a first-in-class, selective inhibitor of TGF-beta 1 & 3, the main pathogenic TGF-beta isoforms; AVID200 spares TGF-beta 2 for optimal safety

• REMINDER - Tesamorelin Study Results on NAFLD Published in Lancet HIV

  10/14/2019

  NAFLD is a substantial cause of liver-related morbidity in people living with HIV and is a precursor of Non-alcoholic steatohepatitis

• BIONIK Laboratories Partners with Intelliware Development to Provide Seamless Connectivity Between InMotionTM Robotic Devices and Hospital Information Systems

  10/14/2019

  BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced it has partnered with Intelliware Development to meet the data connectivity needs of hospitals and healthcare facilities utilizing sensored technologies nationwide.

• Chalmers Group of Companies Acquires LYNX Product Group

  10/11/2019

  Chalmers Group of Companies, a privately owned Canadian corporation that manufactures and supplies niche quality equipment to the medical and transportation industries, has announced the acquisition of LYNX Product Group, which designs, develops, and manufactures both standard and custom animal care washing, disinfection, filling, and conveying systems.

• AgraFlora Organics Elects Not To Proceed with Proposed Eviana Health Takeover Bid

  10/11/2019

  AgraFlora Organics International Inc.  (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, announces that the Company has elected not to proceed with its proposed takeover bid of Eviana Health Corporation (“Eviana”) due to

• Profound Medical Corp. Announces Share Consolidation in Connection With Proposed Nasdaq Listing

  10/11/2019

  Profound Medical Corp. (TSX: PRN; OTCQX: PRFMF) (“Profound” or the “Company”) is pleased to announce that today it implemented a consolidation (the “Consolidation”) of its issued and outstanding common shares (“Common Shares”) on the basis of one post-Consolidation Common Share for every ten pre-Consolidation Common Shares.